Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 4
Results: 12
Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 441, doi. 10.1007/s00262-016-1944-0
- By:
- Publication type:
- Article
Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 427, doi. 10.1007/s00262-016-1945-z
- By:
- Publication type:
- Article
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 461, doi. 10.1007/s00262-016-1946-y
- By:
- Publication type:
- Article
Delivery of foreign cytotoxic T lymphocyte epitopes to tumor tissues for effective antitumor immunotherapy against pre-established solid tumors in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 451, doi. 10.1007/s00262-016-1948-9
- By:
- Publication type:
- Article
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 475, doi. 10.1007/s00262-016-1949-8
- By:
- Publication type:
- Article
Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 491, doi. 10.1007/s00262-016-1950-2
- By:
- Publication type:
- Article
Inclusion of BLIMP-1 effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot study.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 515, doi. 10.1007/s00262-016-1951-1
- By:
- Publication type:
- Article
Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 503, doi. 10.1007/s00262-016-1953-z
- By:
- Publication type:
- Article
Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 523, doi. 10.1007/s00262-017-1955-5
- By:
- Publication type:
- Article
Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 537, doi. 10.1007/s00262-017-1959-1
- By:
- Publication type:
- Article
In memory of Professor Enrico Mihich: Editor-in-Chief of Cancer Immunology, Immunotherapy 1982-2012.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 415, doi. 10.1007/s00262-016-1917-3
- By:
- Publication type:
- Article